PMPRB Advocacy Update – Open Letter to Prime Minister Justin Trudeau & other decision makers urging them to put our lives first!
Following our successful advocacy campaign during the last three months of 2020 which led to a six-month delay in implementation of the new PMPRB Regulations – now set to come into force on July 1, 2021 – we promised you we would keep our eyes on this important issue....
ADVOCACY UPDATE: NEW PMPRB REGULATIONS DELAYED UNTIL JULY 1, 2021
Our message was heard! On December 30, 2020 – just two days before the new PMPRB Guidelines were due to come into force – the Government of Canada advised stakeholders that implementation of the amended Patented Medicines Regulations has been further delayed...
NEWS RELEASE: Federal Government Must Delay Drug Pricing Reform to Safeguard Patient Lives During COVID-19
NEWS RELEASE: Federal Government Must Delay Drug Pricing Reform to Safeguard Patient Lives During COVID-19 Today, the Canadian Association of PNH Patients, issued a news release pressing the Federal government to again delay the implementation of the new PMPRB...
Submission to Standing Committee on Health Study on PMPRB Reforms
On November 6, PNH Canada submitted a brief to the House of Commons Standing Committee on Health (HESA) to inform the study it is undertaking on the Final Guidelines issued by the Patented Medicine Prices Review Board (PMPRB) on October 23, 2020. Our submission...
We want to hear from you!!
We hope you will join our advocacy efforts by using the tools on this website. Please reach out to the Canadian Association of PNH Patients (PNHCA) with any questions about our work, to share your PNH stories, or to learn more about our advocacy campaign.
Email: advocacy@pnhca.org
Stay in Touch!
Sign up now to receive the latest news and updates from the Canadian Association of PNH Patients.